Emcure Pharmaceuticals Limited — Others, 10-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Emcure Pharmaceuticals has submitted a confirmation certificate regarding the dematerialization of securities for the quarter ended December 31, 2024, in compliance with SEBI regulations. MUFG Intime India Pvt. Ltd., the company’s registrar, confirmed that the securities received for dematerialization have been processed and listed on the relevant stock exchanges. This update reflects the company’s commitment to maintaining efficient capital management and shareholder engagement. For investors, this news supports a positive outlook as it ensures streamlined operations regarding share transactions, enhancing liquidity and confidence in the company's governance practices.